EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences

Nina Kastner, Mohammad N Islam, Michael Dybek, Evelyn Roth, Simon Heisinger, Marion Holy, Kathrin Jäntsch, Donna Walther, Thomas Stockner, Michael H Baumann, Simon D Brandt, Jason Wallach und 2 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Nina Kastner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Serotonin Plasma Membrane Transport Proteins, Norepinephrine Plasma Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institute on Drug Abuse Intramural Research Program, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolintane is a synthetic stimulant that acts by inhibiting the uptake of dopamine and norepinephrine into neurons. Initially prescribed for attention deficit hyperactivity disorder and narcolepsy, its medical use was discontinued due to concerns about abuse liability. Here, we explored structure-activity relationships for novel fluoro and methyl-ring-substituted prolintanes synthesized via a modified one-pot Mannich Barbier reaction. Radiotracer flux assays in transfected human embryonic kidney 293 (HEK293) cells and rat brain synaptosomes revealed that prolintane analogs display potent uptake inhibition at the dopamine transporter (DAT) and norepinephrine transporter (NET), with weaker effects at the serotonin transporter (SERT). Across all compounds, SERT inhibitory potencies were at least 10-fold weaker at human SERT (hSERT) compared to rat SERT (rSERT). Methyl substitution at the 2-, 3-, or 4-ring position enhanced SERT inhibition potency relative to DAT, lowering the DAT/SERT ratio and suggesting reduced abuse liability. Fluorine substitution also enhanced SERT potency relative to DAT, however, to a lesser extent. Interestingly, prolintane and its analogs induced hSERT-mediated ionic currents and [3H]serotonin efflux, which was not seen in rat brain synaptosomes. Overall, these findings indicate that prolintane analogs act as potent DAT and NET inhibitors, but they can also act as substrates and evoke serotonin release in cells expressing hSERT, classifying them as hybrid compounds at human monoamine transporters. Our study demonstrates how ring modifications alter prolintane pharmacology, emphasizing the need for future investigations into therapeutic and adverse effects of these compounds. Moreover, the species difference in SERT-releasing activity for prolintane analogs warrants further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serotonin Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsDopamine Plasma Membrane Transport ProteinsHumansAnimalsHEK293 CellsRatsSynaptosomesStructure-Activity RelationshipLigandsSpecies SpecificityBrainRats, Sprague-DawleyMale

Stichwörter der Autor:innen

molecular docking approachmonoamine transportersprolintane analogsserotonin transporter mediated effluxstructure-activity relationship

Substanzen

Serotonin Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsDopamine Plasma Membrane Transport ProteinsLigandsSLC6A4 protein, human

Autor:innen und Institutionen

  • Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA.
  • Designer Drug Research Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, USA.
  • The Alexander Shulgin Research Institute, Lafayette, California, USA.
  • Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; Center for Ad…

Förderung

  • Intramural NIH HHS
  • National Institute on Drug Abuse Intramural Research Program
  • National Institute on Drug Abuse
  • Austrian Science Fund

Zitieren

APA

Kastner, N., Islam, M. N., Dybek, M., Roth, E., Heisinger, S., Holy, M., Jäntsch, K., Walther, D., Stockner, T., Baumann, M. H., Brandt, S. D., Wallach, J., Sitte, H. H., & Kudlacek, O. (2025). Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110903

Vancouver

Kastner N, Islam MN, Dybek M, Roth E, Heisinger S, Holy M, et al. Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110903

BibTeX
@article{Kastner2025,
  author = {Kastner, Nina and Islam, Mohammad N and Dybek, Michael and Roth, Evelyn and Heisinger, Simon and Holy, Marion and Jäntsch, Kathrin and Walther, Donna and Stockner, Thomas and Baumann, Michael H and Brandt, Simon D and Wallach, Jason and Sitte, Harald H and Kudlacek, Oliver},
  title = {Prolintane analogs as hybrid monoamine transporter ligands: Structural determinants and species differences},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110903}
}
Kostenlos starten →